HES Coils
HEAT: Hydrogel Endovascular Aneurysm Treatment Trial
"Coiling of small-to-medium aneurysms with second-generation HES resulted in less recurrence when compared to BPC, without increased harm. These data further support the use of the second-generation HES for the embolization of intracranial aneurysms."
- Patients
600
- Country
US
- Clinical Centers
46
- Design
RCT (297 HES vs 303 BPC)
- Scope
Patients 18 – 75 y.o. with a untreated aneurysm, ruptured or unruptured, 3-14mm, H&H<4 treatable with Hydrocoils or Bare platinum coils.
- Purpose
Evaluate recurrence rates of second-generation hydrogel coils HydroCoils for treating aneurysms compared to bare platinum coils.
Endpoints
Aneurysm Recurrence Post procedure to 24 months, defined as any progression on the Raymond-Roy (RR) Aneurysm Occlusion Scale, (assessed by Corelab)
Efficacy results
Aneurysm recurrence: 4.4% HES vs 15.4% BPC
Packing density: 32,5% HES vs 24,7% BPC (p<.001)
Initial complete occlusion: 17,8% HES vs 28,3% BPC
Retreatment: 5.2% HES vs 8.3% BPC
Safety results
Patients with event related to procedure/device: 21.6% HES vs 24.8% BPC
Mortality: 2.4% HES vs 3.0% BPC
Device or procedure-related hemorrhage: 1.7% HES vs 1.3% BPC
Study publications
LINK TO STUDY PAGE ClinicalTrials.gov ID NCT01407952
Please refer to IFU for the full list of risks, contraindications, warnings, and precautions.
Explore more studies
Request more information
By submitting, you agree to our privacy policy.